NATR Nature's Sunshine Products Inc.
XNAS
11.20
Delayed
Stock quote, options chain, IV rank, technicals, AI analysis, and institutional ownership. Iron condor setups Expected move IV rank history Fibonacci levels Insider trading
Market data may be delayed, incomplete, or inaccurate. Not a recommendation to buy, sell, or hold any security. Verify quotes with your broker before trading. See Terms §17.
What changed
Recent filings, trades and moves- 52-Week Range
- $9.38 – $28.14
- YTD
- -46.59%
- IV Rank (30D)
- 100.0
- Straddle Price
- $9.10
- P/C Vol Ratio
- 3.64
- Market Cap
- $0.2B
- Open
- $10.95
- Day Range
- $10.95 – $11.06
- Volume
- 4,917
- Prev Close
- $10.93
A blended fair-value estimate combining up to six valuation methods. Each method is weighted by how well it fits the company — DCF down-weights for unprofitable names; DDM only fires for steady dividend payers; comparables down-weight when peer multiples disagree.
- DCF (quality-aware) — projects free cash flow with a horizon that scales to business quality. True compounders (quality 6/6) get 10 years explicit + 10 years fade before terminal; cyclical/struggling names (quality 0-1) get a 5-year terminal cliff. Quality is scored from ROE, gross margin, growth, FCF margin, debt load, and FCF consistency — the same factors that drive market premium for compounders.
- Market-Implied Growth (in Model Inputs) — reverse-DCF that answers "what growth rate is the market pricing in?". Lets you sanity-check the deviation: if implied growth is plausible for the business, the model's bearish flag may be wrong; if implausible, the market may be over-extrapolating.
- DDM (Gordon Growth Dividend Model) — values the stream of future dividends. Only used when trailing yield ≥ 2% and dividend payments are stable — below that the dividend is a token payout and Gordon (which values only the dividend stream) systematically underprices growth names, so those route to DCF + comparables + market anchor instead.
- P/E, EV/EBITDA, P/B, P/S — applies the peer-group median multiple to this company's per-share metric. Peers come from the same set as the "Related symbols" card. Earnings/sales metrics are forward-tilted by the company's recent revenue growth (capped at 25%) so they're comparable to peers' growth-embedded multiples — mimics how analysts use NTM rather than TTM. Per-multiple weights are biased by company quality (e.g. P/B down-weighted for asset-light tech).
- Market Anchor (SMA50) — the 50-day moving average, weighted by recent trading-range stability (tighter Bollinger bands → higher weight). Captures information fundamentals miss (forward consensus, sentiment, supply/demand) — but only when recent trading is steady enough that the market has converged on a view. During wild breakouts or breakdowns the anchor's weight collapses.
- Options Expected (B-L 30d) — the risk-neutral expected stock price at 30-day options expiration, derived from the full implied-volatility surface via Breeden-Litzenberger (second derivative of call price wrt strike → implied PDF, then E[S_T]). Forward-looking, captures all options-implied information (smile, skew, term structure) in one number. Weighted by chain liquidity. SP500-only at present (pre-computed daily). Backtest evidence: adds modest alpha across most bucket × holding combos.
- Blended value — weighted average. Confidence reflects how many methods fired and how tight peer dispersion is.
- Deviation pill — green when blended FV ≥ 10% above current price (undervalued); red when ≥ 10% below; grey otherwise.
| 10-yr Treasury (rf) | 4.84% |
| Beta vs SPY | 0.67 |
| Cost of Equity (CAPM) | 8.17% (VRP-adj) |
| WACC | 8.25% |
| Volatility Risk Premium | +36.0pp (IV − HV30) |
| Effective Tax Rate | 34.8% |
| Rev. Growth (YoY, DCF input) | -8.8% |
| DCF Horizon | 10 years explicit + fade |
| Free Cash Flow (TTM) | $0.0B |
| Return on Equity (TTM) | 8.5% |
| Book / Price | 83.8% — banking bias active (P/B is primary) |
| Gross Margin (TTM) | 73.2% |
| FCF Margin (TTM) | 2.2% |
| Debt / Equity | 0.00 |
| Quality Score | 2/6 — normal (10y DCF) |
| Market-Implied Growth | -5.0% (reverse-DCF on current price) |
| SMA 50 | $12.75 (Market Anchor value) |
| SMA 20 / Bollinger Mid | $12.17 |
| Bollinger Width / SMA20 | 21.8% (drives anchor stability) |
| Net Debt | $-0.1B |
| Market Cap | $0B |
| Method | Implied Price | Weight | Detail |
|---|---|---|---|
| DCF | $9.66 | 26% | |
| DDM (Gordon) | n/a | 0% | |
| Peer P/E | $25.94 | 8% | median 25.7× · 4 peers |
| Peer EV/EBITDA | $41.94 | 8% | median 16.1× · 4 peers |
| Peer P/B | $24.47 | 8% | median 2.6× · 4 peers |
| Peer P/S | $43.74 | 8% | median 1.6× · 4 peers |
| Market Anchor (SMA50) | $12.75 | 44% | stability 85% (BB-width) |
| Options Expected (B-L 30d) | $9.71 | 0% | 5 strikes · skew +0.52 |
- Industry (SIC)
- PHARMACEUTICAL PREPARATIONS (2834) · industry map
- Exchange
- XNAS
- Market Cap
- $0.2B
- Employees
- 806
- List Date
- 1980-08-07
- CIK
- 0000275053
- Last Earnings
- Nov 4 after close · −20.1% vs ±17.1% expected
- Headquarters
- Lehi, UT
- Homepage
- https://www.natr.com
Natures Sunshine Products Inc is a natural health and wellness company mainly engaged in the manufacturing and direct selling of nutritional and personal care products. The following Companies' product lines include: General health: Assorted health products related to blood sugar, bone health, cellular health, etc. Immune: offer products that support and strengthen the human immune system, Cardiovascular: Ingredients to give the cardiovascular system optimum support. Digestive: regulates intestinal and digestive functions, Personal care: personal care products for external use, and Weight mana…
Each spoke is this symbol's rank within its sector (0–100; the dotted ring marks the sector median at 50). Higher is more constructive for a long. One spoke — News sentiment — is an absolute reading, not a sector rank. Grayed spokes have no data. A fuller shape is a summary, not a recommendation.
| Month | '21 | '22 | '23 | '24 | '25 | '26 | Avg |
|---|---|---|---|---|---|---|---|
| Jan | 10.92% | -6.02% | 23.80% | -1.86% | -4.46% | 20.27% | 7.11% |
| Feb | -2.66% | -2.77% | 5.34% | -0.39% | 5.12% | 4.69% | 1.55% |
| Mar | 12.51% | -0.47% | -0.29% | 16.42% | -11.87% | -13.71% | 0.43% |
| Apr | 6.72% | -3.72% | 5.18% | -6.80% | -5.01% | 10.99% | 1.23% |
| May | -1.54% | -26.06% | 6.07% | -20.66% | 25.90% | -20.18% | -6.08% |
| Jun | -13.02% | -10.86% | 21.44% | 0.00% | 5.34% | 4.81% | 1.29% |
| Jul | 1.27% | -3.69% | 1.23% | 14.07% | -5.66% | -8.03% | -0.13% |
| Aug | -1.27% | -7.09% | 22.17% | -15.96% | 6.65% | -33.07% | -4.76% |
| Sep | -16.20% | -16.00% | -0.66% | -0.95% | -7.62% | -8.51% | -8.32% |
| Oct | 6.04% | 0.24% | 5.92% | -5.24% | -13.37% | -2.70% | -1.52% |
| Nov | 7.73% | 4.83% | -2.62% | 23.87% | 49.56% | -9.07%* | 12.38% |
| Dec | 7.43% | -1.54% | -0.80% | -12.53% | 2.47% | -- | -0.99% |
| Total | 14.16% | -55.12% | 121.46% | -17.96% | 37.60% | -49.73% | 8.40% |
Quick-reference for reading the values below. Indicators combine to confirm a view — no single one is a trade signal on its own.
- SMA 20 / 50 / 200 — price above = uptrend, below = downtrend. SMA 50 crossing SMA 200 is the golden/death cross.
- EMA 12 / 26 — faster-reacting averages; 12 above 26 is short-term bullish.
- MACD — bullish when MACD > signal (green badge), bearish when below. Divergence from price often precedes reversals.
- ADX (14) — trend strength regardless of direction. <20 range, 20–25 weak trend, 25–50 trend, >50 strong trend.
- +DI / −DI — +DI > −DI favors bulls; the reverse favors bears. Read alongside ADX.
- RSI (14) — <30 oversold, >70 overbought. 40–60 is neutral; trending names can stay extreme.
- Stochastic %K / %D — <20 oversold, >80 overbought. %K crossing %D is an early momentum signal.
- Williams %R — inverted scale: <−80 oversold, >−20 overbought.
Oscillators work best in range-bound markets; in strong trends they give premature reversal signals.
- Bollinger Bands — price at upper band = overbought, lower = oversold. Narrow bands (squeeze) often precede expansion.
- OBV — cumulative volume; rising OBV confirms uptrend, falling OBV confirms downtrend. Divergence from price is a warning.
- Vol SMA 20 / Vol ROC — today's volume vs. 20-day average. Positive ROC with price move = conviction.
- ATR / True Range — average daily $ move; sizing and stop-loss reference.
- HV 20 / 30 / 60 — realized (historical) volatility. Compare to IV on the options cards: IV > HV = rich premium.
Confluence matters: trend + momentum + volume agreeing carries far more weight than any single indicator. For how these feed the spread scanner score, see the algorithm docs →
Trend Indicators
Momentum Oscillators
Volume & Volatility
Data Summary
Here is the comprehensive stock analysis report for NATR:
Executive Summary
Overall Assessment: NEUTRAL with confidence level 6/10.
Key Drivers:
- Strong fundamentals reflected in recent news headlines, particularly positive sentiment around product launches and partnerships.
- Low volatility compared to market, suggesting a relatively stable trading environment.
Primary Risks:
- Potential for price compression due to low volatility, potentially limiting upside potential.
- Risk of unexpected negative news or regulatory changes that could impact the stock's performance.
Investment Thesis: NATR appears to be a stable company with a strong track record of product launches and partnerships. While there is no clear catalyst for a significant move at this time, the stock's low volatility suggests it may be a good candidate for long-term investors seeking stability.
Recent News Sentiment Impact:
- Positive news headlines have been dominating recent coverage, which could continue to support the stock's price.
- However, the lack of any major catalysts in the near term may limit upside potential.
Technical Analysis
Trend Direction: Medium-term (1-3 months) - NATR is trending upward, but at a relatively slow pace.
Support/Resistance Levels:
- Resistance: $27.69 (upper Bollinger Band)
- Support: $19.56 (lower Bollinger Band)
Momentum Signals:
- RSI: 28.51 (oversold), indicating potential for short-term bounce.
- MACD: -1.11 / Signal: -0.13 / Histogram: -0.98 (bearish), suggesting bearish momentum.
- Bollinger Bands: neutral signal, as price is near the middle band.
Volume Analysis:
- Volume SMA 20: 104867.10
- On-Balance Volume (OBV): 2011638.38
- Volume Rate of Change: -5.40% - indicating a slight decrease in trading activity.
News & Sentiment Analysis
Recent Headlines Summary:
- Five recent news articles with positive sentiment, highlighting product launches and partnerships.
- No major negative or regulatory-related headlines in the past few months.
Sentiment Assessment: Positive (80%).
Catalyst Identification:
- Upcoming earnings release in Q3 2026 may provide a catalyst for a potential move.
- Any new product launches or partnerships could also drive the stock's price.
Market Narrative:
- The overall market narrative is neutral, with some sectors showing strength and others weakness. NATR's recent performance appears to be driven by its own fundamentals rather than broader market trends.
Risk & Volatility Assessment
Risk Assessment: Low (confidence level 8/10).
Beta Interpretation: 0.43 - indicating low risk relative to the overall market.
Volatility Regime:
- Current volatility is relatively low compared to historical levels.
- The options market appears to be pricing in a relatively stable trading environment, with a moderate expected move of $4.80 by expiration.
Options Market Signals:
- IV Rank: 13.7% (low) - indicating historically low implied volatility.
- Put/Call Volume Ratio: 0.14 (bullish sentiment).
Downside Protection:
- Support levels are in place at $19.56, with some room for price compression before reaching the lower Bollinger Band.
Market Context & Positioning
Sector Performance:
- NATR is outperforming its sector peers in recent months.
- The company's recent performance appears to be driven by its own fundamentals rather than broader market trends.
Institutional Activity:
- Institutional trading activity has been relatively quiet, with no major buying or selling pressure in the past few weeks.
Correlation Analysis:
- NATR is showing a relatively low correlation to the overall market, indicating some independence from broader market trends.
- The stock's recent performance appears to be driven by its own fundamentals rather than broader market trends.
Relative Valuation:
- NATR is trading within a relatively narrow range, with some room for price compression before reaching the lower Bollinger Band.
Key Levels & Action Items
Critical Price Levels:
- Resistance: $27.69 (upper Bollinger Band)
- Support: $19.56 (lower Bollinger Band)
Breakout/Breakdown Levels:
- Breakout above $27.69 could trigger a significant move upward.
- Breakdown below $19.56 could indicate a more bearish trend.
Time-Sensitive Catalysts:
- Earnings release in Q3 2026 may provide a catalyst for a potential move.
- Any new product launches or partnerships could also drive the stock's price.
Risk Management:
- Stop-loss levels should be set around $20.50 to protect against significant losses.
- Position sizing considerations should focus on the company's recent performance and sector trends.
Please note that this report is based on the provided data, and actual market conditions may differ. It is essential to stay up-to-date with the latest news and market developments when making investment decisions.
| Earnings Date | Timing | Expected Move | Actual Move | Ratio | Outcome |
|---|---|---|---|---|---|
| 2023-05-09 | After-Close | 27.75% | 1.02% | 0.04x | Within |
| 2023-11-07 | After-Close | 7.56% | 4.33% | 0.57x | Within |
| 2024-03-12 | After-Close | 9.19% | 15.64% | 1.70x | Exceeded |
| 2024-05-08 | After-Close | 35.09% | 0.89% | 0.03x | Within |
| 2024-08-09 | After-Close | 25.34% | 6.65% | 0.26x | Within |
| 2024-11-07 | After-Close | 21.46% | 7.50% | 0.35x | Within |
| 2025-03-12 | After-Close | 16.83% | 0.44% | 0.03x | Within |
| 2025-07-31 | After-Close | 21.06% | 12.78% | 0.61x | Within |
| 2025-11-06 | After-Close | 18.75% | 30.52% | 1.63x | Exceeded |
| 2026-03-10 | After-Close | 9.37% | 1.28% | 0.14x | Within |
| 2026-05-07 | After-Close | 8.15% | 1.30% | 0.16x | Within |
| 2026-08-06 | After-Close | 24.09% | 19.47% | 0.81x | Within |
| 2026-11-04 | After-Close | 17.13% | 20.09% | 1.17x | Exceeded |
Earnings calendar: this week’s reports with expected vs actual moves →
NATR Options Activity & IV Rank
NATR IV rank history, 52-week IV rank and IV percentile →
Volatility Metrics
Options Flow · All expiries
ATM Options Pricing
Chain Summary
Each spread is ranked by a composite score built in three stages. Full documentation →
score = P(profit) × (credit / spread_width)
P(profit) from short leg delta (1 − |delta|), penalised above 85%. Credit uses mid-price to handle illiquid chains fairly.
Calendars: the long leg is valued at the short leg’s expiration (Black-Scholes at its current IV) across the range of prices the short leg’s IV implies, giving the best-case profit (R/R = that over the debit) and P(profit).
RR and BF (30-delta) from the persisted per-symbol skew snapshot — wing strikes picked by real greeks.delta, not a moneyness proxy. Put skew boosts bull puts, penalises bear calls. High butterfly boosts iron condors. Calendars are skew-neutral.
- RSI <40 bullish / >60 bearish
- MACD crossover + histogram trend
- Price vs SMA 50 & SMA 200
- Stochastic %K <20 / >80
- Williams %R <−80 / >−20
- Blended ATR + straddle expected-move penalty
- Bollinger Band signal (+ counter-trend penalty)
- BB width — vol contraction boost for ICs
- IV rank ≥ 75 → strong boost for credit spreads
- IV rank < 25 → penalty (selling cheap vol)
- Min open interest across all legs
- OI < 100 → −0.10 · OI < 500 → −0.05
score = base_score × skew_multiplier × tech_multiplier
Both multipliers are shown per spread. Beta is informational only — ATR already captures realized vol. Full algorithm documentation →
Scanning bull put, bear call, iron condor and calendar spreads…
Estimated net dealer gamma is at the 5th percentile of this name's own daily history, near the low end of its range. This describes current positioning; it is not a forecast or a trading signal.
Net dealer gamma is an estimate of the aggregate gamma held by options market makers across this name's option chain, weighted by open interest. Dealer positions aren't public, so it uses a standard simplifying assumption: dealers are treated as long the calls and short the puts that are open. Actual dealer books can differ.
Gamma percentile ranks today's estimate against this name's own daily history, from 0% (the lowest reading on record) to 100% (the highest). Raw gamma scales with how much open interest a chain carries, so it isn't comparable across names; the percentile is. The badge marks the bottom 20% as low and the top 20% as high.
Tilts run from −1 to +1 and show how lopsided the estimated dealer exposure is. GEX tilt compares call gamma with put gamma. Vanna tilt describes how the hedge would shift if implied volatility changed, and charm tilt how it would shift with the passage of time.
This card describes estimated positioning and where it sits historically. It is not a forecast of price direction or volatility and not a trading signal. Market-wide view: Dealer positioning screener.
IV(put wing) − IV(ATM), in vol pointsHow much the OTM put trades above (or below) the at-the-money strike. Measures the height of the put-side tail relative to ATM — i.e. how expensive crash insurance is on this name.
- Positive (typical) — wing IV > ATM IV. Standard equity put skew: portfolios bid up crash protection, so OTM puts trade richer than ATM.
- Near zero or negative (unusual) — wing IV ≤ ATM IV. Flat or inverted put side. Common when there's no fear demand, in tightly mean-reverting names, or right after an earnings catalyst clears.
- Percentile vs own 3-yr history: high = wings rich (good time to sell wing premium); low = wings cheap (good time to buy protection).
- Not directional — high or low wings don't predict up or down moves. It's a price tag on tail insurance, not a forecast.
IV(call wing) − IV(put wing), equal delta on each sideWhich side of the smile is the market paying up for? Measures the tilt of the surface — call skew vs put skew at matched deltas.
- Negative (typical) — puts richer than calls. Standard equity behavior: hedging demand makes puts carry a premium. Most large-caps sit in the −1 to −5 vol-point range.
- Strongly negative (< −5 pts) — heavy downside hedging, elevated fear, or an upcoming catalyst (earnings, FDA, macro event). Worth flagging.
- Positive — calls richer than puts. Unusual for equities; signals bullish momentum, short-squeeze positioning, or takeover/M&A speculation.
- Near zero — symmetric surface. Market sees roughly equal up/down risk. Rare for large-caps; more common in commodities and FX.
Wing-vs-ATM tells you how expensive the tails are. Risk Reversal tells you which side is favored. Combined:
- High wing percentile + deeply negative RR → strong put bid; stress or major event priced in. Owning protection costs a premium; selling put premium is dangerous.
- Low wing percentile + near-zero RR → complacency; insurance cheap and balanced. Good environment to add cheap downside hedges.
- Positive RR + elevated wings → call-side fear-of-missing-out; common in squeeze setups. Upside calls expensive, downside puts not bid.
Percentile is the rank of today's reading within ~3 years of this symbol's own history. High percentile = wings are rich relative to history; not a directional signal. Skew is read off the chain in real time, not from CBOE SKEW.
Loading the implied volatility surface…
Loading the implied volatility smile…
Risk Metrics
Analysis Details
Data Points: 251
Period: 252 trading days
Low volatility - stock moves less than market
| Investor | Value | Share of their portfolio | Rank | Q/Q shares | Source |
|---|---|---|---|---|---|
| Renaissance Technologies Hedge fund Jim Simons | $11.5M | #982 of 3138 | -0.8% | 13F | |
| Millennium Management Hedge fund Izzy Englander | $358K | #3296 of 3716 | new | 13F | |
| Point72 Hedge fund Steve Cohen | $341K | #1707 of 1945 | -25.6% | 13F | |
| Rockefeller Capital Management Family office Rockefeller family | $9K | #4070 of 4729 | +93.1% | 13F |
Hedge funds, activists, holding companies and family offices we track, from their latest 13F (quarter-end value) and Form 4 filings in the last 3 years. Family offices · all institutions
NATR Institutional Ownership (13F)
Filings for 2026-06-30 · 47 already for 2026-09-30Institutional managers with $100M+ AUM file Form 13F-HR quarterly, due 45 days after quarter end. Holdings are reported gross at quarter-end market value — they are a snapshot, not a real-time position.
- Shares — long equity positions in this name, aggregated across share classes.
- Calls / Puts — notional value of long call / put exposure where this ticker is the underlying.
- % of Float — holder's reported shares divided by the latest diluted shares outstanding. Sums above 100% indicate large custodian / prime broker positions where the same shares are reported by multiple filers.
- Custodian badge — filers with more than 5,000 holdings are typically broker-dealers / custodians reporting customer-held shares, not active managers.
Each filer is counted once at its latest 13F-HR filing. New filings are ingested on a weekly cadence.
| # | Filer | Notional Value | % of Total | Period |
|---|
| # | Filer | Notional Value | % of Total | Period |
|---|---|---|---|---|
| 1 | Simplex Trading, LLC Custodian | $1.27K | 100.00% | 2026-09-30 |
NATR Insider Trading (Form 4)
Latest: 2026-11-09| Filed | Reporter | Role | Action | Shares | Avg Price | Net $ | Link |
|---|---|---|---|---|---|---|---|
| 2026-11-09 | PRESCOTT GROUP AGGRESSIVE SMALL CAP MASTER FUND GP | 10%+ Owner | Buy (P) | +291,666 | $9.77 | $2.85M | EDGAR |
| 2026-11-06 | Daniel C Norman | EVP & President, Asia | Mixed Tax −1,136 · Exer +2,804 |
+1,668 | $12.84 | -$14.6K | EDGAR |
| 2026-11-06 | Nathan G Brower | EVP, General Counsel | Mixed Tax −935 · Exer +2,308 |
+1,373 | $12.84 | -$12.0K | EDGAR |
| 2026-11-06 | Kenneth G. Romanzi | Chief Executive Officer | Tax (F) | −15,021 | $12.84 | -$192.9K | EDGAR |
| 2026-11-06 | Jonathan David Lanoy | SVP, Chief Accounting Officer | Mixed Tax −519 · Exer +1,277 |
+758 | $12.84 | -$6.7K | EDGAR |
| 2026-11-06 | Bryant J Yates | EVP & President, Europe | Mixed Exer +2,804 · Tax −1,136 |
+1,668 | $12.84 | -$14.6K | EDGAR |
| 2026-09-15 | Ruth Ann Perkins | EVP, Chief Financial Officer | Award (A) | +75,433 | — | EDGAR | |
| 2026-09-03 | Jonathan David Lanoy | SVP, Chief Accounting Officer | Award (A) | +7,210 | — | EDGAR | |
| 2026-08-19 | PRESCOTT GROUP AGGRESSIVE SMALL CAP MASTER FUND GP | 10%+ Owner | Buy (P) | +20,000 | $14.69 | $293.8K | EDGAR |
| 2026-08-10 | PRESCOTT GROUP CAPITAL MANAGEMENT, L.L.C. | 10%+ Owner | Buy (P) | +141,389 | $16.40 | $2.32M | EDGAR |
| 2026-06-29 | Kevin R. Herbert | EVP & President, North America | Tax (F) | −1,976 | $21.02 | -$41.5K | EDGAR |
NATR Insider Holdings
9 insiders · @ $10.93| # | Insider | Role | Shares | Disclosed Exposure | Lifetime OM Net | Filings | Last Filed |
|---|---|---|---|---|---|---|---|
| 1 | PRESCOTT GROUP AGGRESSIVE SMALL CAP MASTER FUND GP | 10%+ Owner | 1,944,486 | $21.25M | $293.8K | 1 | 2026-08-19 |
| 2 | PRESCOTT GROUP CAPITAL MANAGEMENT, L.L.C. | 10%+ Owner | 1,901,414 | $20.78M | $2.32M | 1 | 2026-08-10 |
| 3 | Kenneth G. Romanzi | Chief Executive Officer | 128,978 | $1.41M | $0 | 1 | 2026-11-06 |
| 4 | Bryant J Yates | EVP & President, Europe | 79,897 | $873.3K | $0 | 1 | 2026-11-06 |
| 5 | Jonathan David Lanoy | SVP, Chief Accounting Officer | 55,765 | $609.5K | $0 | 2 | 2026-11-06 |
| 6 | Daniel C Norman | EVP & President, Asia | 48,944 | $535.0K | $0 | 1 | 2026-11-06 |
| 7 | Kevin R. Herbert | EVP & President, North America | 46,890 | $512.5K | $0 | 1 | 2026-06-29 |
| 8 | Nathan G Brower | EVP, General Counsel | 45,455 | $496.8K | $0 | 1 | 2026-11-06 |
| 9 | Ruth Ann Perkins | EVP, Chief Financial Officer | 39,384 | $430.5K | $0 | 1 | 2026-09-15 |
NATR Board & Officers
As of SEC filings through Nov 9, 2026Directors 8
- Robert D Straus · since Jun 8, 2017
- Heidi Wissmiller · since Aug 13, 2020
- Curtis Kopf · since Jan 3, 2022
- Tess Roering · since Jan 3, 2022
- Rong Yang · since Jun 1, 2022
- Steven J. Fasching · since Nov 11, 2024
- Katie May · since Feb 4, 2025
- Kenneth G. Romanzi · since Oct 30, 2025
Officers 11
- Kenneth G. Romanzi · Chief Executive Officer · since Oct 30, 2025
- Daniel C Norman · EVP & President, Asia · since Mar 18, 2022
- Bryant J Yates · EVP & President, Europe · listed since Mar 2022
- Kevin R. Herbert · EVP & President, North America · since Jul 11, 2023
- Ruth Ann Perkins · EVP, Chief Financial Officer · since Sep 1, 2026
- Jonathan David Lanoy · SVP, Chief Accounting Officer · listed since Apr 2023
- Kevin Gregory Fuller · Global Chief Marketing Officer · since Sep 26, 2024
- Nathan G Brower · EVP, General Counsel · since Dec 4, 2017
- Martin A. Gonzalez · EVP, Global Supply Chain · since Jul 21, 2022
- Erich A Fritz · EVP, Global Supply Chain · since Dec 8, 2025
- Tracee Comstock · VP, Human Resources · since Apr 20, 2023
10% owners 5
- Phil Frohlich · since Oct 17, 2008
- Prescott Group Aggressive Small Cap II LP (entity) · since Jul 31, 2025
- Prescott Group Aggressive Small Cap LP (entity) · since Jul 31, 2025
- Prescott Group Aggressive Small Cap Master Fund Gp (entity) · since Jul 31, 2025
- Prescott Group Capital Management, L.l.c. (entity) · listed since Aug 2025
Changes in the last 10 years (49)
| Sep 1, 2026 | Ruth Ann Perkins became EVP, Chief Financial Officer |
| Dec 8, 2025 | Erich A Fritz became EVP, Global Supply Chain |
| Oct 30, 2025 | Kenneth G. Romanzi became a director |
| Oct 30, 2025 | Kenneth G. Romanzi became Chief Executive Officer |
| Aug 11, 2025 | Prescott Group Capital Management, L.l.c. first listed as a 10% owner in an SEC filing |
| Jul 31, 2025 | Prescott Group Aggressive Small Cap Master Fund Gp became a 10% owner |
| Jul 31, 2025 | Prescott Group Aggressive Small Cap LP became a 10% owner |
| Jul 31, 2025 | Prescott Group Aggressive Small Cap II LP became a 10% owner |
| Jun 27, 2025 | Shanghai Fosun Pharmaceutical (Group) Co., Ltd. reported in an SEC filing no longer being a 10% owner |
| Jun 27, 2025 | Fosun Pharma USA Inc. reported in an SEC filing no longer being a 10% owner |
| Jun 5, 2025 | Fosun Pharma USA Inc. became a 10% owner |
| May 28, 2025 | The company announced the departure of Terrence Moorehead from the board in an SEC filing |
| May 28, 2025 | The company announced the departure of Terrence Moorehead as CEO in an SEC filing |
| Feb 4, 2025 | The company announced the departure of Richard D Moss from the board in an SEC filing |
| Feb 4, 2025 | Katie May became a director |
| Nov 11, 2024 | Steven J. Fasching became a director |
| Sep 26, 2024 | Kevin Gregory Fuller became Global Chief Marketing Officer |
| Nov 2, 2023 | Sarah Crockett became Global Chief Marketing Officer |
| Jul 11, 2023 | Kevin R. Herbert became EVP & President, North America |
| Apr 21, 2023 | Jonathan David Lanoy listed as SVP, Chief Accounting Officer (previously SVP, Finance - Interim CFO) in SEC filings |
| Apr 20, 2023 | Tracee Comstock became VP, Human Resources |
| Dec 19, 2022 | The company announced the departure of Leslie Shane Jones as EVP & Chief Financial Officer in an SEC filing |
| Dec 19, 2022 | Leslie Shane Jones became EVP & Chief Financial Officer |
| Sep 6, 2022 | The company announced the departure of Joseph W Baty as EVP & Chief Financial Officer in an SEC filing |
| Sep 6, 2022 | Jonathan David Lanoy became SVP, Finance - Interim CFO |
| Jul 21, 2022 | Martin A. Gonzalez became EVP, Global Supply Chain |
| Jun 1, 2022 | Rong Yang became a director |
| May 31, 2022 | The company announced the departure of Shirley Wu from the board in an SEC filing |
| Mar 29, 2022 | Edward Silcock became EVP & President, North America |
| Mar 22, 2022 | Bryant J Yates listed as EVP & President, Europe (previously President of International) in SEC filings |
| Mar 18, 2022 | Daniel C Norman became EVP & President, Asia |
| Jan 3, 2022 | Tess Roering became a director |
| Jan 3, 2022 | Curtis Kopf became a director |
| Sep 22, 2021 | Shirley Wu became a director |
| Sep 17, 2021 | Willem Mesdag reported in an SEC filing no longer being a 10% owner |
| Sep 17, 2021 | Rmcp Gp LLC reported in an SEC filing no longer being a 10% owner |
| Sep 17, 2021 | Red Mountain Partners, L.p. reported in an SEC filing no longer being a 10% owner |
| Sep 17, 2021 | Red Mountain Capital Partners LLC reported in an SEC filing no longer being a 10% owner |
| Sep 17, 2021 | Red Mountain Capital Management Inc reported in an SEC filing no longer being a 10% owner |
| Jul 1, 2021 | Tariq Hassan became a director |
| Aug 13, 2020 | Heidi Wissmiller became a director |
| Jun 8, 2020 | Prescott Group Capital Management, L.l.c. reported in an SEC filing no longer being a 10% owner |
| Aug 7, 2019 | Lily Zou became a director |
| Apr 3, 2019 | Terrence Moorehead first listed as CEO in an SEC filing |
| Sep 25, 2018 | Terrence Moorehead became a director |
| Aug 2, 2018 | Hongfei Jia became a director |
| May 25, 2018 | Richard D Moss became a director |
| Dec 4, 2017 | Nathan G Brower became EVP, General Counsel |
| Jun 8, 2017 | Robert D Straus became a director |
- Prev
- 1
Not reported recently (24)
- John Christopher Teets · Last reported as a director in an SEC filing dated May 9, 2024
- Sarah Crockett · Last reported as Global Chief Marketing Officer in an SEC filing dated Mar 13, 2024
- Wynnefield Partners Small Cap Value LP I · Last reported as a 10% owner in an SEC filing dated Sep 19, 2022
- Wynnefield Partners Small Cap Value LP · Last reported as a 10% owner in an SEC filing dated Sep 19, 2022
- Wynnefield Capital Inc · Last reported as a 10% owner in an SEC filing dated Sep 19, 2022
- Nelson Obus · Last reported as a 10% owner in an SEC filing dated Sep 19, 2022
- Joshua Landes · Last reported as a 10% owner in an SEC filing dated Sep 19, 2022
- Wynnefield Capital Management LLC · Last reported as a 10% owner in an SEC filing dated Sep 19, 2022
- Wynnefield Small Cap Value Offshore Fund Ltd · Last reported as a 10% owner in an SEC filing dated Sep 19, 2022
- Wynnefield Capital, Inc. Profit Sharing Plan · Last reported as a 10% owner in an SEC filing dated Sep 19, 2022
- Edward Silcock · Last reported as EVP & President, North America in an SEC filing dated Jul 25, 2022
- Mary Beth Springer · Last reported as a director in an SEC filing dated May 6, 2022
- Tariq Hassan · Last reported as a director in an SEC filing dated Jul 6, 2021
- Robert B Mercer · Last reported as a director in an SEC filing dated May 6, 2021
- Lily Zou · Last reported as a director in an SEC filing dated May 6, 2021
- Jeffrey D Watkins · Last reported as a director in an SEC filing dated May 8, 2020
- Kristine F Hughes · Last reported as a director in an SEC filing dated Dec 9, 2019
- Hongfei Jia · Last reported as a director in an SEC filing dated May 10, 2019
- Susan M Armstrong · Last reported as EVP & Chief Operations Officer in an SEC filing dated Feb 14, 2019
- Gregory Probert · Last reported as CEO & Chairman of the Board in an SEC filing dated Feb 15, 2018
- Albert R Dowden · Last reported as a director in an SEC filing dated May 11, 2017
- Rebecca Lee Steinfort · Last reported as a director in an SEC filing dated May 11, 2017
- Richard Strulson · Last reported as EVP/Gen. Counsel/CCO in an SEC filing dated Feb 14, 2017
- Paul Noack · Last reported as President, China & New Markets in an SEC filing dated Jan 18, 2017
NATR Proposed Insider Sales (Form 144)
Latest: 2025-07-08What is Form 144? A notice of intent to sell restricted or control stock under Rule 144. Affiliates (officers, directors, 10%+ owners) and holders of restricted shares must file Form 144 when planning to sell more than 5,000 shares or $50,000 in any 3-month rolling window.
How it relates to Form 4: Form 144 is filed before the trade (up to 90 days in advance); Form 4 is filed within 2 business days after the trade executes. Not every Form 144 results in a sale — the filer may cancel or delay. Look for the corresponding Form 4 on the Insider Activity card to confirm a sale actually happened.
10b5-1 plans: Trades made under a pre-scheduled Rule 10b5-1 plan are not discretionary — they execute automatically on dates set months earlier, regardless of news. High 10b5-1 percentages mean less per-filing signal value, though cumulative selling volume still matters.
"Notice value": Aggregate market value the filer wrote into the Form 144 — i.e. the size of the planned sale, not necessarily the executed dollars. An amended notice (Form 144/A) replaces the original it amends, and cancelled notices are dropped, so neither is double-counted above. A filed value that is clearly inconsistent with the share count at the stock's price (a filer typo) shows as a dash and is left out of the totals.
Source & freshness: Sourced from public Form 144 filings. Refreshed daily; new filings typically appear here the morning after they are filed.
| Filed | Filer | Role | Shares | Notice Value | Planned Sale | Broker | Plan | Link |
|---|---|---|---|---|---|---|---|---|
| 2025-07-08 | MOSS RICHARD D | Director | 1,000 | $15.9K | 2025-07-08 | Wells Fargo Clearing Services | — | EDGAR |
| 2025-07-07 | MOSS RICHARD D | Director | 3,500 | $55.0K | 2025-07-07 | Wells Fargo Clearing Services | — | EDGAR |
| 2025-07-03 | MOSS RICHARD D | Director | 1,500 | $23.0K | 2025-07-03 | Wells Fargo Clearing Services | — | EDGAR |
| 2025-07-01 | MOSS RICHARD D | Director | 1,500 | $22.1K | 2025-07-01 | Wells Fargo Clearing Services | — | EDGAR |
| 2025-06-25 | MOSS RICHARD D | Director | 2,000 | $29.8K | 2025-06-25 | Wells Fargo Clearing Services | — | EDGAR |
| 2025-06-23 | MOSS RICHARD D | Director | 3,000 | $44.2K | 2025-06-23 | Wells Fargo Clearing Services | — | EDGAR |
| 2025-06-20 | MOSS RICHARD D | Director | 1,500 | $21.9K | 2025-06-20 | Wells Fargo Clearing Services | — | EDGAR |
| 2025-06-18 | MOSS RICHARD D | Director | 1,000 | $14.5K | 2025-06-18 | Wells Fargo Clearing Services | — | EDGAR |
| 2025-06-13 | MOSS RICHARD D | Director | 734 | $10.6K | 2025-06-13 | Wells Fargo Clearing Services | — | EDGAR |
| 2025-06-03 | MOSS RICHARD D | Director | 1,000 | $14.5K | 2025-06-03 | Wells Fargo Clearing Services | — | EDGAR |
| Filing Date | Accession | Link |
|---|
| # | ETF | Provider | Weight | $ Exposure | ETF AUM | As Of |
|---|---|---|---|---|---|---|
| 1 | AVUV Avantis U.S. Small Cap Value ETF | Avantis | 0.03% | $8.2M | $31.6B | 2026-11-06 |
| 2 | VTI Vanguard Morningstar Total Stock Market ETF | Vanguard | 0.00% | $5.3M | — | 2026-09-30 |
| 3 | IWM iShares Russell 2000 ETF | iShares (BlackRock) | 0.01% | $4.0M | $77.9B | 2026-11-06 |
| 4 | DFAT Dimensional US Targeted Value ETF | Dimensional | 0.01% | $3.0M | — | 2026-11-06 |
| 5 | DFSV Dimensional US Small Cap Value ETF | Dimensional | 0.01% | $2.4M | — | 2026-11-06 |
| 6 | VXF Vanguard Extended Market ETF | Vanguard | 0.00% | $2.2M | — | 2026-09-30 |
| 7 | VDC Vanguard Consumer Staples ETF | Vanguard | 0.02% | $2.1M | — | 2026-09-30 |
| 8 | DFAS Dimensional US Small Cap ETF | Dimensional | 0.00% | $1.4M | — | 2026-11-06 |
| 9 | DFMC Dimensional US Micro Cap ETF | Dimensional | 0.02% | $1.3M | — | 2026-11-06 |
| 10 | VTWO Vanguard Russell 2000 ETF | Vanguard | 0.01% | $1.1M | — | 2026-09-30 |
| 11 | IWN iShares Russell 2000 Value ETF | iShares (BlackRock) | 0.01% | $1.1M | $14.2B | 2026-11-06 |
| 12 | DFAC Dimensional US Core Equity 2 ETF | Dimensional | 0.00% | $784,749 | — | 2026-11-06 |
| 13 | IWC iShares Micro-Cap ETF | iShares (BlackRock) | 0.04% | $481,052 | $1.2B | 2026-11-06 |
| 14 | IWO iShares Russell 2000 Growth ETF | iShares (BlackRock) | 0.00% | $411,256 | $14.2B | 2026-11-06 |
| 15 | DCOR Dimensional US Core Equity 1 ETF | Dimensional | 0.00% | $371,841 | — | 2026-11-06 |
| 16 | JPSE JPMorgan Diversified Return U.S. Small Cap Equity ETF | JPMorgan | 0.06% | $331,305 | $574.9M | 2026-11-09 |
| 17 | BFOR Barrons 400 ETF | Nport | 0.13% | $299,527 | — | 2026-08-31 |
| 18 | AVSC Avantis U.S. Small Cap Equity ETF | Avantis | 0.01% | $277,826 | $3.2B | 2026-11-06 |
| 19 | PRFZ Invesco RAFI US 1500 Small-Mid ETF | Nport | 0.01% | $259,552 | — | 2026-07-31 |
| 20 | EES WisdomTree U.S. SmallCap Fund | Nport | 0.03% | $228,399 | — | 2026-06-30 |
| 21 | DXUV Dimensional US Vector Equity ETF | Dimensional | 0.00% | $160,180 | — | 2026-11-06 |
| 22 | VTWV Vanguard Russell 2000 Value ETF | Vanguard | 0.01% | $124,958 | — | 2026-09-30 |
| 23 | PKW Invesco BuyBack Achievers ETF | Invesco | 0.01% | $124,125 | — | 2026-11-08 |
| 24 | AVUS Avantis U.S. Equity ETF | Avantis | 0.00% | $104,385 | $14.3B | 2026-11-06 |
| 25 | SMLV State Street® SPDR® US Small Cap Low Volatility Index ETF | SPDR (State Street) | 0.03% | $82,178 | $258.6M | 2026-11-06 |
Quarterly filings sourced from SEC 10-Q / 10-K reports. TTM tiles aggregate the most recent four quarters; bars show the last ~12 quarters oldest → newest.
- Revenue — top-line sales. Look for consistent YoY growth; seasonal businesses need same-quarter comparisons (Q4 '24 vs Q4 '23).
- Net Income — bottom-line profit after all expenses. Can be volatile from one-time items; red bars = net loss.
- Diluted EPS — net income per share assuming options/converts are exercised. Direct input to the P/E ratio.
- Operating Cash Flow — cash generated from core operations, before capex and financing. Harder to manipulate than net income; growing OCF is a quality signal.
- Sequential growth — quarter-over-quarter trend. Accelerating bars are a momentum signal.
- YoY growth — compare to the same quarter a year earlier to remove seasonality.
- Quality — OCF should roughly track Net Income over time. Large divergence (net income ≫ OCF) flags accruals risk.
- Margins — scan the bar ratios: Net Income / Revenue tells you margin trend without needing a separate chart.
TTM (trailing-twelve-month) smooths seasonality and is used for the P/E calculation. Filings appear 30–90 days after the period closes.
Quarterly figures (12 quarters)
| Quarter | Period End | Revenue | Net Income | Diluted EPS | Op. Cash Flow |
|---|---|---|---|---|---|
| Q2 '26 | 2026-06-30 | $116.98M | $3.54M | $0.19 | $835.00K |
| Q1 '26 | 2026-03-31 | $122.89M | $5.12M | $0.29 | $-1.85M |
| Q4 '25 | 2025-12-31 | $123.81M | $4.11M | $0.23 | $9.99M |
| Q3 '25 | 2025-09-30 | $128.34M | $5.33M | $0.30 | $18.41M |
| Q2 '25 | 2025-06-30 | $114.75M | $5.33M | $0.28 | $4.34M |
| Q1 '25 | 2025-03-31 | $113.25M | $4.75M | $0.25 | $2.61M |
| Q4 '24 | 2024-12-31 | $118.20M | $-321.00K | $-0.02 | $12.23M |
| Q3 '24 | 2024-09-30 | $114.61M | $4.35M | $0.23 | $9.55M |
| Q2 '24 | 2024-06-30 | $110.55M | $1.35M | $0.07 | $1.38M |
| Q1 '24 | 2024-03-31 | $110.99M | $2.32M | $0.12 | $2.18M |
| Q4 '23 | 2023-12-31 | $108.94M | $8.96M | $0.46 | $9.58M |
| Q3 '23 | 2023-09-30 | $111.20M | $2.83M | $0.15 | $14.29M |
Ratios derived from TTM financials and the current market price, sampled daily. History chart shows how expensive the stock is today relative to its own recent past.
- P/E — price / TTM earnings. Rough market rule: 10–15 value, 15–25 market, >30 growth/premium. Negative when earnings are negative.
- P/B — price / book value. Useful for financials and asset-heavy names; meaningless for asset-light software.
- P/S — price / TTM revenue. Useful when earnings are negative or noisy (early-stage growth).
- EV/EBITDA — capital-structure-neutral. <10 cheap, 10–15 reasonable, >20 rich. Good for comparing across leverage profiles.
- EV/Sales — like P/S but accounts for debt + cash. Compare within sector.
- ROE — return on equity. >15% strong, >25% exceptional. Caution: high leverage inflates ROE.
- ROA — return on assets. Leverage-neutral; >5% solid, >10% exceptional.
- Div Yield — annual dividend / price. Compare to 10Y Treasury; sustained yield >6% often signals distress.
- FCF Yield — free cash flow / market cap. >5% is attractive; negative means burning cash.
- Debt/Equity — leverage. <1 conservative, >2 aggressive. Sector-dependent (utilities naturally high, tech low).
- Current Ratio — short-term liquidity. >1.5 comfortable, <1 raises short-term solvency flags.
- Compare current level to the 3-year band: near the high end = relatively expensive; near the low = relatively cheap.
- Multiples expanding while earnings are flat = sentiment-driven rally.
- Multiples compressing while earnings grow = value coming from fundamentals.
NATR vs Peers
Related companies, largest first| Company | Market cap | P/E | Revenue growth | YTD | IV rank |
|---|---|---|---|---|---|
| LLY Eli Lilly & Co. | $1.26T | 46.2 | +45.5% | +31.7% | 36 |
| MDT Medtronic plc | $131.5B | 24.7 | +9.8% | +4.6% | 57 |
| HUM Humana Inc. | $50.8B | 42.0 | +18.5% | +68.1% | 9 |
| EHC Encompass Health Corporation Common Stoc | $13.9B | 22.1 | +9.4% | +32.9% | 30 |
| BTSG BrightSpring Health Services, Inc. Commo | $13.8B | 51.2 | +28.0% | +88.0% | 19 |
| DVA DaVita Inc. | $11.7B | 13.1 | +5.9% | +55.5% | 22 |
| ENSG The Ensign Group, Inc. | $10.6B | 27.5 | +17.5% | +6.1% | 20 |
| NVST Envista Holdings Corporation Common stoc | $4.2B | 44.2 | +11.9% | +18.3% | 2 |
| NATR Nature's Sunshine Products Inc. | $191M | 10.9 | +6.8% | −47.4% | 100 |
| Peer median | $13.8B | 34.8 | +14.7% | +32.3% | 21 |
P/E uses the latest reported trailing-12-month diluted EPS; "—" means no positive earnings or no data.
Regulatory short-interest reports publish on a bi-weekly settlement cadence; short-volume is reported daily by the trade-reporting facilities. Float is derived from insider-ownership filings.
- Short Interest — total shares currently sold short as of the settlement date. Lags real time by ~8 business days.
- SI % of Float — short interest / free float. The key crowding metric.
- Days to Cover — short interest / avg daily volume. How many full trading days it would take shorts to buy back. High DTC + catalyst = squeeze fuel.
- Short Vol Ratio — today's short-sale volume / total volume. Intraday selling pressure proxy (not the same as short interest).
- Free Float — shares available for public trading (total shares minus insider / restricted).
- Float % — free float / shares outstanding. <50% = tightly held, more prone to squeezes.
- SI % of Float < 5% — typical, no particular signal.
- 5–15% — elevated; watch for catalysts (earnings, guidance, macro).
- 15–30% — heavily shorted; tight-float names in this range have produced notable squeezes historically.
- >30% — extreme; borrow is likely expensive and squeeze risk is material.
- Days to Cover > 5 combined with high SI% amplifies squeeze potential.
- Trend matters more than level. Rapidly rising short interest often precedes negative catalysts or heavy hedging.
- A sudden drop in SI after a rally may indicate a squeeze in progress.
Short interest is reported mid-month and end-of-month; short volume is daily.